#AAN2018 – Venlafaxine Reduces Fibromyalgia Symptoms in Women Without Depressive Disorder, Study Shows

#AAN2018 – Venlafaxine Reduces Fibromyalgia Symptoms in Women Without Depressive Disorder, Study Shows
Treatment with the antidepressant venlafaxine (brand name Effexor XR) reduces pain, muscle stiffness, and interference in daily life in women with fibromyalgia who don't have depressive disorder, according to researchers. The study, "The Effects of Venlafaxine vs Gabapeptine in Fibromyalgia," will be presented in a poster session titled General Neurology, at the 2018 American Academy of Neurology (ANN) Annual Meeting on April 26. The meeting is April 21-27 in Los Angeles. The study's abstract was recently published in the journal Neurology. Fibromyalgia causes widespread pain and increased pain sensitivity, as well as fatigue, muscle stiffness, sleep disturbance, and depression. Patients with fibromyalgia have few effective treatments to choose from. Two options are the antiepileptic medication gabapentin (Neurontin), and venlafaxine, a selective serotonin and norepinephrine reuptake inhibitor (SNRIs) antidepressant. Researchers compared the effects of venlafaxine with gabapentin 90 in fibromyalgia patients without depressive disorder. The study included 163 ambulatory patients
Subscribe or to access all post and page content.